Skip to content

SCREENER CHART SD50 CALENDAR NEWS

...

Nexalin Technology, Inc. (NXL) Stock · SELL · CRISIS | LOPJLB

Nexalin Technology, Inc. (NXL)

Healthcare · Medical - Devices · NASDAQ · US

$4.11-4.86%Close

SELLCRISIS · day 3

NXL▼ SELL

$4.11-4.86%

Overview FinancialsFin EarningsEarn Analyst & RatingsAnalyst News Holders & ETFsHold Options

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $90M
Beta: 3.98
P/E (TTM): -0.31

Short % float: 0.07%
Days to cover: 1.0
SI change: -8.6%

1W: -45.56%
1M: -18.61%

vs SPY 1W: -47.12%
vs SPY 1M: -20.38%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which…

Employees: 8
Headquarters: US
Founded: 2022
Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares out: 22.0M
Float: 80.9%

nexalin.com ↗

Key executives

Mark White — President, Chief Executive Officer & Director

Carolyn Shelton — Executive Vice President of Clinical, Quality & Regulatory Affairs

David Owens — Chief Medical Officer, Member of Scientific Advisory Board & Director

SEC filings

EDGAR · CIK 15273520 · NXL

All filings
10-K
10-Q
8-K
Form 4

Analyst consensus

Buy

Bullish1100.0%

Neutral00.0%

Bearish00.0%

Last$4.11

Company news

globenewswire.com · 2d ago

Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued Listing

defenseworld.net · 4d ago

Critical Survey: Enovis (NYSE:ENOV) vs. Nexalin Technology (NASDAQ:NXL)

globenewswire.com · 9d ago

Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation

globenewswire.com · 11d ago

Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization Strategy

defenseworld.net · 19d ago

LogicMark (OTCMKTS:LGMKD) vs. Nexalin Technology (NASDAQ:NXL) Head to Head Comparison

globenewswire.com · 37d ago

Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer's Patients; ADAS-Cog Subscale Analysis to Guide Design of Planned U.S. Alzheimer's Pilot Study

globenewswire.com · 44d ago

Nexalin Technology Announces Reverse Stock Split

Market news & ticker search · RSS for NXL

LOPJLB

Independent quant research on U.S. equities & ETFs. Not personalized advice.

Product

Screener Chart Compare SD50 Thesis News Calendar

Desk

Market Heatmap Market Hours FOMC Desk Treasury Rates Congress Trades Prediction Markets

Research

How It Works Methodology Track Record Editorial Blog Changelog

Ledgers

Bull Spreads Cash-Secured Puts Covered Calls Long Puts Long Calls

Screeners

CEF Screener REIT Screener BDC Screener Preferred Screener Dividend Screener ETF Screener Crypto Screener S&P 500 Screener

Company

Pricing About Contact

Agents

GitHub·Research Chat·MCPENT·Developers

© 2026 LOPJLB Research. All rights reserved.

@lopjlb contact@lopjlb.com

RANGE

LOPJLB.COM

OHLC🔒EMALEVELS🔒STOP🔒FLIP🔒52WSIGNALS🔒BUY🔒SELL🔒EXH🔒EXH ZONE